The Hindu Business Line : Aurobindo drug gets FDA nod

Aurobindo Pharma Ltd has announced that the company has received approval from the US Food and Drug Administration for terbinafine hydrochloride tablets 250 mg. This approval has been received on the first day after the expiry of the relevant patent, according to a notice to the stock exchanges from the company. Terbinafine hydrochloride tablets 250 mg are the generic equivalent of Novartis anti-fungal Lamisil Tablets. The brand product has annual sales of approximately $6 54 million in the US.

— Our Bureau

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
IFC lends $40 m to West Coast Paper Mills

ONGC firms up plans to explore at Contai block

Supply to Dabhol: Petronet signs LNG pact with RasGas

Bhilwara Energy to raise Rs 105 cr thru pvt equity

Britannia, Danone play down impact

San Motors may contract manufacture for French co

Moody’s downgrades Tata Power

Veta sets up corporate training unit

GVMC refuses water to Jindal alumina refinery

Aurobindo drug gets FDA nod

Ashok Leyland forms joint venture with Finnish co

Zenotech bets big on biological entities

Sun Pharma to raise Rs 3,500 cr